. Capital Expenditure Capital Expenditure was THB 266m in Q1 2018, and THB 188m in Q1 2017. Generally, capital expenditure for production equipment will follow the increase in sales, particularly in the IC
Expenditure Capital Expenditure was THB 503m in Q2 2018, and THB 430m in Q2 2017. Generally, capital expenditure for production equipment will follow the increase in sales, particularly in the IC division
high at approximately 4 times current liabilities. Operating Cashflow (Recurring EBITDA) in Q3 2019 was THB 664m which was 40% lower than Q3 2018 was THB 1,098m. Capital Expenditure Net Capital
approximately 4 times current liabilities. Operating Cashflow (Recurring EBITDA) in Q1 2020 was THB 766m which was 68% higher than Q1 2019 was THB 455m. Capital Expenditure Net Capital Expenditure was THB 230m in
incurring higher expenditure concerning preparation for the pre-opening of Excellence Center in Early 2018. In addition, in 2017 the Company has benefited from its efficient excess liquidity management
, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 2. Costs of sales and gross profit Costs of sales were Baht 117 .60 million in the first nine months of 2019, a surge of Baht 32 .42 million
improvement expenditure. 3. The consolidated net loss was 2.38%, decreased from the same period of last year at net profit 5.16%, mainly caused by reduction in gross profit margin while selling and
2023 Agenda 2 • Motivation & Research Questions • Data • Methodology & Result • Key Takeaways The surge in sustainable investing and the dematerialized world trends has strengthened, drawing increased
March 2018 increased by 19% yoy mainly from the surge of provisions for employee benefit and other liabilities. Most of the increase of other liabilities was income tax payable on 2017 profit because
due to economic slowdown, which results in a decline in advertising expenditure in print and advertising. Consolidated print and advertising revenue for the year-ended 31 December 2019 was 588.6 million